Laizure S C, Madlock L, Cyr M, Self T
Department of Clinical Pharmacy, University of Tennessee, Memphis 38163, USA.
Ther Drug Monit. 1997 Jun;19(3):361-3. doi: 10.1097/00007691-199706000-00019.
The authors describe a case of furosemide possibly inhibiting the hypoprothrombinemic effect of warfarin. The initiation of furosemide dosing in a patient receiving a stable dose of warfarin was associated with an 28% decrease in the international normalized ration (INR). Using normal volunteers, two previous controlled studies of an interaction between warfarin and chlorthalidone, and between warfarin and spironolactone, assert that volume depletion produced by forced diuresis results in the inhibition of warfarin's hypoprothrombinemia. Consistent with this hypothesis, the authors found that their patient's hematocrit (believed to reflect hydration status) correlated with the INR: r2 = 0.78, p < 0.05. This case provides further evidence suggesting that acute diuresis can decrease the hypoprothrombinemic effect of warfarin.
作者描述了一例速尿可能抑制华法林低凝血酶原血症效应的病例。在接受稳定剂量华法林治疗的患者中开始使用速尿给药后,国际标准化比值(INR)下降了28%。此前两项针对正常志愿者进行的关于华法林与氯噻酮、华法林与螺内酯之间相互作用的对照研究表明,强制利尿导致的容量耗竭会抑制华法林的低凝血酶原血症。与该假设一致,作者发现其患者的血细胞比容(被认为可反映水合状态)与INR相关:r2 = 0.78,p < 0.05。该病例提供了进一步的证据,表明急性利尿可降低华法林的低凝血酶原血症效应。